Created to address higher standards in pharmaceutical compounding, STAQ Pharma operates FDA-registered 503B outsourcing facilities that produce sterile compounded medications for hospitals and healthcare systems. Its facilities were built from the ground up to cGMP standards, with the original Denver site opening in 2018 and a much larger Columbus facility producing its first commercial batch in 2023. Backed and guided by healthcare systems, STAQ supplies medications nationwide while focusing on drug-shortage resilience and consistent quality.
FDA-Registered 503B Outsourcing Facility
registration
FDA-Registered and Inspected Facility
registration
DEA-Registered Facility
registration
cGMP Standards
compliance_program
ProRx PharmaProRx Pharma is an Exton, Pennsylvania, FDA-registered 503B outsourcing facility that compounds sterile and non-sterile preparations for healthcare providers, with a particular focus on preventative care and medications affected by shortages. Its 6,888-square-foot pharmaceutical and manufacturing facility uses ISO-classified cleanrooms, automation and robotics, while the company’s pharmaceutical and healthcare team brings more than 70 years of cumulative industry experience. ProRx also holds a DEA Controlled Substance Registration Certificate and supports providers with independently tested preparations and extended Beyond-Use Dates.EXTON, PA
PGRrxPGRrx is a 503B pharmaceutical outsourcing facility that produces sterile and non-sterile compounded medicines to help healthcare providers navigate drug shortages and tailor dosage forms to patient needs. Founded by pharmacist Amit Gupta, the company also supports CMC and clinical-trial research, drawing on his experience leading sterile and non-sterile compounding in inpatient institutions. Its work is organized around supplying safe, personalized pharmaceutical access to communities facing gaps in availability.EXTON, PA
Pine PharmaceuticalsFounded in 2014 by father and son Alfonse Muto and Alfonse J. Muto, Pine Pharmaceuticals is an independently owned FDA-registered 503B outsourcing facility that prepares compounded and repackaged drugs for hospitals, surgery centers, and specialty practices. From its 75,000-square-foot facility, the company distributes millions of ready-to-use units each year, with a particular focus on ophthalmic products and hospital supply needs. Pine’s roots reach back to local compounding pharmacies dating to 1985, and its operations follow cGMP standards with on-campus quality-control testing.TONAWANDA, NY
Carie Boyd PharmaceuticalsFounded in 1965 as a local community pharmacy, Carie Boyd Pharmaceuticals now compounds office-use and patient-specific medications for healthcare providers and patients nationwide. Its FDA-registered 503B outsourcing facility and 503A specialty pharmacy are especially known for implantable hormone pellets, with the company having pioneered an automated pellet-compounding process. The facilities follow cGMP and USP standards while developing customized medications for needs that commercial products may not meet.DENTON, MD